PhRMA· @PhRMA · X·· 5 天前AI 评分15
AI 导读
当 PBM 掌控着决定保险公司承保哪些药品的处方集、拥有自己的竞争对手，并参与决定患者在药房柜台面对的价格时，很难称之为竞争。 患者理应拥有一个围绕其护理而建、而非围绕 PBM 利润而建的体系。了解更多请访问 http://PhRMA.org/AskYourPBM
正文
It’s hard to call it competition when PBMs control the formulary that determines which medicines will be covered by insurers, own their competitors, and help determine the prices patients face at the pharmacy counter.
Patients deserve a system built around their care, not a PBM's bottom line. Learn more at http://PhRMA.org/AskYourPBM
来源：PhRMA · x.com